Becton, Dickinson and Company (LON:0R19)
171.39
-3.10 (-1.77%)
At close: Jun 16, 2025
LON:0R19 Revenue
Becton, Dickinson and Company had revenue of $5.27B USD in the quarter ending March 31, 2025, with 4.50% growth. This brings the company's revenue in the last twelve months to $20.87B, up 5.84% year-over-year. In the fiscal year ending September 30, 2024, Becton, Dickinson and Company had annual revenue of $20.18B with 4.16% growth.
Revenue (ttm)
$20.87B
Revenue Growth
+5.84%
P/S Ratio
2.25
Revenue / Employee
$281.99K
Employees
74,000
Market Cap
36.28B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 20.18B | 806.00M | 4.16% |
Sep 30, 2023 | 19.37B | 502.00M | 2.66% |
Sep 30, 2022 | 18.87B | -261.00M | -1.36% |
Sep 30, 2021 | 19.13B | 3.06B | 19.02% |
Sep 30, 2020 | 16.07B | -1.22B | -7.03% |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 30, 2016 | Pro | Pro | Pro |
Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
Becton, Dickinson and Company News
- 8 days ago - Becton, Dickinson and Company (BDX) Presents at Goldman Sachs 46th Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 8 days ago - Becton, Dickinson: A Dividend King Facing Challenges Offers Value - Seeking Alpha
- 10 days ago - June's Top Dividend Aristocrat Fat Pitches: Blue-Chip Bargains You Can't Miss - Seeking Alpha
- 13 days ago - June's Dividend Kings: 3 Ideal Buys In 25 "Safer" Dogs - Seeking Alpha
- 20 days ago - BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease - PRNewsWire
- 21 days ago - Best Dividend Aristocrats For June 2025 - Seeking Alpha
- 21 days ago - BD to Present at Goldman Sachs 46th Annual Global Healthcare Conference - PRNewsWire
- 27 days ago - Cancer Patients Face Elevated Risk of Carrying Antimicrobial Resistant 'Superbugs' - PRNewsWire